<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="136245">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02001480</url>
  </required_header>
  <id_info>
    <org_study_id>12-039</org_study_id>
    <nct_id>NCT02001480</nct_id>
  </id_info>
  <brief_title>Surrogate Markers for Sudden Cardiac Death in Patients With Diabetes Mellitus and End Stage Renal Disease</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>RWTH Aachen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RWTH Aachen University</source>
  <oversight_info>
    <authority>Germany: according to the professional code of conduct for doctors</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim: Patients with type 2 diabetes mellitus (T2DM) and hemodialysis due to diabetic
      nephropathy exhibit a high risk for sudden cardiac death (SCD). Preliminary data suggest
      that beta-blocker treatment may reduce arrhythmias and mortality in this high-risk
      population. However, no results from large-scale clinical outcome trials with beta-blockers
      exist in this patient group and a broad, scientifically unapproved use of beta-blocker
      treatment may not be justified due to potential harmful side-effects such as AV-block or
      hypotension. In addition, we are lacking identified ECG surrogate parameters for SCD in this
      high-risk population and on the occurrence of arrhythmias in temporary relationship to
      hemodialysis sessions.

      Therefore, the present study will identify surrogate parameters of SCD in hemodialysis
      patients with T2DM and in an interventional trial investigate the suppressive effect of
      beta-blockers on these identified ECG markers.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">October 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>ECG surrogate markers compared to cardiac events</measure>
    <time_frame>Analysis will be performed after last patient is out</time_frame>
    <safety_issue>No</safety_issue>
    <description>Recruiting Period: October 2013 - April 2014 (6 months)/ Last patient out: April 2014/ Data cleaning, processing, analysis, study report: May 2014 - October 2014 (6 months)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Continuous glucose monitoring is performed to identify episodes of hypoglycaemia</measure>
    <time_frame>Analysis will be done after last patient is out</time_frame>
    <safety_issue>No</safety_issue>
    <description>Recruiting/active Period: October 2013 - April 2014 (6 months)/ Last patient out: April 2014/ Data cleaning, processing, analysis, study report: May 2014 - October 2014 (6 months)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Diabetes Mellitus Type 2</condition>
  <condition>End Stage Renal Disease</condition>
  <arm_group>
    <arm_group_label>Echocardiography</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>12 lead holter for 7 days
CGM = continuous Glucose Monitoring</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>12 lead Holter</intervention_name>
    <description>12 lead Holter measurements will be performed for 7 days</description>
    <arm_group_label>Echocardiography</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CGM Continuous Glucose Monitoring</intervention_name>
    <description>CGM will be performed continously for 7 days</description>
    <arm_group_label>Echocardiography</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with diabetes mellitus type 2

          -  chronic hemodialysis at least since 3 months

          -  aged above 18 years

          -  written informed consent

          -  legally competent

        Exclusion Criteria:

          -  intake of bets-blockker within the last four weeks

          -  pregnancy and breast feeding

          -  abuse of drugs and alcohol

          -  missing compliance

          -  life expectancy &lt; 6 month
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nikolaus Marx, Univ.-Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Internal Medicine University Hospital Aachen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nikolaus Marx, Univ.-Prof.</last_name>
    <phone>++492418089300</phone>
    <email>nmarx@ukaachen.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>regioMed-Kliniken GmbH</name>
      <address>
        <city>Coburg</city>
        <state>Bayern</state>
        <zip>96450</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hans-Jörg Rothe, Dr.med.</last_name>
      <phone>++4995612233305</phone>
    </contact>
    <investigator>
      <last_name>Ketteler Markus, Univ.-Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hans-Jörg Rothe, Dr. med.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Würzburg</name>
      <address>
        <city>Würzburg</city>
        <state>Bayern</state>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christph Wanner, Univ.-Prof.</last_name>
      <phone>++4993120139030</phone>
      <email>Wanner_C@medizin.uni-wuerzburg.de</email>
    </contact>
    <investigator>
      <last_name>Christoph Wanner, Univ.-Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Internal Medicine I University Hospital RWTH Aachen</name>
      <address>
        <city>Aachen</city>
        <state>NRW</state>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Nikolaus Marx, Univ.-Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 27, 2013</lastchanged_date>
  <firstreceived_date>October 23, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
    <mesh_term>Death, Sudden, Cardiac</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
